You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
龍津藥業(002750.SZ):預計上半年淨利326.94萬元至490.40萬元 同比扭虧為盈
格隆匯 07-13 16:57

格隆匯7月13日丨龍津藥業(002750.SZ)公佈2021年半度業績預吿,預計上半年歸屬於上市公司股東的淨利潤326.94萬元至490.40萬元,同比扭虧為盈。基本每股收益0.0082元/股至0.0122元/股。

本報吿期,母公司加強對目標終端進行精細化分類管理,對商務體系進一步完善,實現產品銷量穩中有增,且產品產量增幅較大,單位生產成本下降,母公司利潤額相應增長;同時,公司新藥研發投入根據項目進展較去年同期減少。上述各因素導致歸屬於上市公司股東的淨利潤較上年同期扭虧為盈。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account